Caribou Biosciences, Inc. (CRBU)
NASDAQ · Healthcare
Caribou Biosciences, Inc. Operating Income 2019–2025
Caribou Biosciences, Inc. annual/quarterly operating income history and growth rate from 2019 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Caribou Biosciences, Inc. operating income for the quarter ending March 31, 2026 was -26.3 M, a 38.76% decrease year-over-year.
- Caribou Biosciences, Inc. operating income for the twelve months ending March 31, 2026 was -146.2 M, a 2.67% increase year-over-year.
- Caribou Biosciences, Inc. annual operating income for 2025 was -148.3 M, a 10.97% decrease from 2024.
- Caribou Biosciences, Inc. annual operating income for 2024 was -166.6 M, a 43.56% increase from 2023.
- Caribou Biosciences, Inc. annual operating income for 2023 was -116.1 M, a 9.08% increase from 2022.
- Caribou Biosciences, Inc. annual operating income for 2022 was -106.4 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Caribou Biosciences, Inc. Operating Income — FAQ
Caribou Biosciences, Inc. (CRBU) operating income over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Caribou Biosciences, Inc.'s operating income?
Caribou Biosciences, Inc. (CRBU) reported operating income of -$148M for fiscal 2025.
Where can I see CRBU's operating income history?
The chart and table above show Caribou Biosciences, Inc.'s operating income by year and by quarter, including the growth rate.